Ocular tuberculosis /
Saved in:
| Imprint: | Cham : Springer, 2017. |
|---|---|
| Description: | 1 online resource |
| Language: | English |
| Series: | Essentials in ophthalmology Essentials in ophthalmology. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11274354 |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | 11274354 | ||
| 005 | 20210625184116.9 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 170605s2017 sz ob 001 0 eng d | ||
| 015 | |a GBB973016 |2 bnb | ||
| 016 | 7 | |a 019287647 |2 Uk | |
| 019 | |a 988773353 |a 989550714 |a 992469905 |a 992886453 |a 999419215 |a 1005777397 |a 1011849660 |a 1048128110 |a 1058151880 |a 1066639987 |a 1086468951 |a 1090370836 |a 1097092740 |a 1112525604 | ||
| 020 | |a 9783319575209 |q (electronic bk.) | ||
| 020 | |a 3319575201 |q (electronic bk.) | ||
| 020 | |z 9783319575193 | ||
| 020 | |z 3319575198 | ||
| 024 | 7 | |a 10.1007/978-3-319-57520-9 |2 doi | |
| 035 | |a (OCoLC)989025523 |z (OCoLC)988773353 |z (OCoLC)989550714 |z (OCoLC)992469905 |z (OCoLC)992886453 |z (OCoLC)999419215 |z (OCoLC)1005777397 |z (OCoLC)1011849660 |z (OCoLC)1048128110 |z (OCoLC)1058151880 |z (OCoLC)1066639987 |z (OCoLC)1086468951 |z (OCoLC)1090370836 |z (OCoLC)1097092740 |z (OCoLC)1112525604 | ||
| 035 | 9 | |a (OCLCCM-CC)989025523 | |
| 037 | |a com.springer.onix.9783319575209 |b Springer Nature | ||
| 040 | |a YDX |b eng |e pn |c YDX |d N$T |d GW5XE |d EBLCP |d UAB |d YDX |d ESU |d AZU |d UPM |d OCLCF |d IOG |d COO |d MERER |d OCLCQ |d U3W |d MERUC |d CAUOI |d KSU |d VT2 |d AU@ |d WYU |d OCLCQ |d LEAUB |d CASUM |d OCLCO |d UKMGB |d UKAHL |d OCLCQ |d ERF |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCQ | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a RC312.5.E9 | |
| 060 | 4 | |a 2018 C-461 | |
| 060 | 4 | |a WW 160 | |
| 066 | |c (S | ||
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 072 | 7 | |a MJQ |2 bicssc | |
| 245 | 0 | 0 | |a Ocular tuberculosis / |c Atul Kumar, Rohan Chawla, Namrata Sharma, editors. |
| 260 | |a Cham : |b Springer, |c 2017. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Essentials in ophthalmology | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |6 880-01 |a Preface; Contents; Contributors; 1: Epidemiological Aspect of Ocular Tuberculosis; Introduction; Epidemiology of Ocular TB in Patients with Pulmonary TB; Ocular TB in Developed Countries; Ocular TB in Developing Countries; Ocular TB in the Immunocompromised; Gender; Laterality; Anatomical Location of Ocular TB; Conclusion; References; 2: Pathogenesis and Pathology of Ocular Tuberculosis; Pathology of Ocular Tuberculosis; Pathogenesis of Ocular Tuberculosis; Immunopathogenesis of Ocular Tuberculosis (Fig. 2.7); Cellular Immunity to MTB. | |
| 505 | 8 | |a Side Effects of ATT Therapy [4, 5] Novel Drug Delivery System for Antitubercular Treatment; Role of Steroids and Immunosuppressives; Factor Associated with Poor Visual Outcome [5]; Treatment of Drug-Resistant TB; New Technologies for Tuberculosis Control: A Framework for Their Adoption, Introduction and Implementation (Geneva, World Health Organization, 2007); Newer Drugs; Treatment of Ocular Tuberculosis in Immunocompromised Patients; Treatment of Ocular Tuberculosis in Paediatric Patients; Conclusions; References; 7: Tubercular Uveitis; Introduction. | |
| 505 | 8 | |a Clinical Spectrum of Intraocular Tuberculosis Diagnostic Challenge; Anterior Uveitis; Investigations; Management; Intermediate Uveitis; Posterior Uveitis; Clinical Manifestations of Posterior Segment Tuberculosis; Choroidal Tubercles; Choroidal Tuberculomas; Serpiginous Choroiditis; Points Favouring an Autoimmune Aetiology; Points Against Autoimmune Aetiology; Points Favouring Tubercular Aetiology; Points Against Tubercular Aetiology; Tubercular Endophthalmitis and Panophthalmitis; References; 8: Tubercular Multifocal Serpiginoid Choroiditis; Introduction. | |
| 520 | |a A concise guide for ophthalmologists detailing tuberculosis, which can cause disease in multiple organs throughout the body, including the eye. Tuberculosis is an infection caused by Mycobacterium tuberculosis. It can affect any part of the eye (intraocular, superficial or surrounding the eye), with or without presence of systemic involvement. Difficulty in obtaining adequate ocular tissue for histopathological and microbiological analysis makes it difficult to conclusively establish a diagnosis of tuberculosis in ocular disorders. Ocular Tuberculosis is a text devoted to in-depth coverage of this topic. Written and edited by international leaders in the field, discussing detailed and practical information on everything from clinical features, ocular imaging studies, and pathology, to investigations, treatment and surgical management of this disease, Ocular Tuberculosis is a truly comprehensive text. | ||
| 504 | |a Includes bibliographical references at the end of each chapters and index. | ||
| 650 | 0 | |a Eye |x Tuberculosis. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Eye |x Tuberculosis. |2 fast |0 (OCoLC)fst00919211 | |
| 650 | 1 | 4 | |a Medicine & Public Health. |
| 650 | 2 | 4 | |a Ophthalmology. |
| 650 | 1 | 2 | |a Tuberculosis, Ocular |x diagnosis. |
| 650 | 2 | 2 | |a Eye Diseases. |
| 650 | 2 | 2 | |a Tuberculosis, Ocular |x therapy. |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Kumar, Atul, |e editor. |0 http://id.loc.gov/authorities/names/n2008205811 | |
| 700 | 1 | |a Chawla, Rohan, |e editor. | |
| 700 | 1 | |a Sharma, Namrata, |e editor. |0 http://id.loc.gov/authorities/names/no2004069177 | |
| 776 | 0 | 8 | |i Print version: |t Ocular tuberculosis. |d Cham : Springer, 2017 |z 9783319575193 |z 3319575198 |w (OCoLC)981117796 |
| 830 | 0 | |a Essentials in ophthalmology. |0 http://id.loc.gov/authorities/names/n2004119373 | |
| 880 | 8 | |6 505-00/(S |a Recent Advances in the Diagnosis of Ocular TBReferences; 3: Imaging Studies for Ocular Tuberculosis; Fundus Fluorescein Angiography; Indocyanine Green (ICG) Angiography; Fundus Autofluorescence; Optical Coherence Tomography (OCT); Ultrasonography; References; 4: Laboratory and Radiological Investigations in the Diagnosis of Ocular Tuberculosis; Introduction; Investigations; Molecular Assays; Imaging; Diagnostic Approach; References; 5: Tuberculin Skin Test and Interferon-γ Release Assays in the Diagnosis of Ocular Tuberculosis; Introduction; Tuberculin Skin Test (TST). | |
| 880 | 8 | |6 505-01/(S |a Interferon-γ Release Assays (IGRAs) Comparison of IGRAs with the TST; Choosing Between the T-SPOT. TB and QFT; Approach to the Diagnosis of Ocular Tuberculosis; Common Diagnostic Strategies; Other Techniques; Direct Evidence; Acid-Fast Smear; Culture of Intraocular Fluid/Tissue; Histopathologic Examination; Polymerase Chain Reaction; Imaging; Conclusion; References; 6: Management of Ocular Tuberculosis; Introduction; Ocular Tuberculosis; Challenges in Management of Ocular Tuberculosis; Pharmacokinetics and Pharmacodynamics of Anti-TB Drugs; Treatment; Monitoring of Response. | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i 5af0d416-3dc6-5f17-9072-bf88aa789da2 |s f68e8641-1255-551c-aba5-a3cbd81c956d |
| 928 | |t Library of Congress classification |a RC312.5.E9 |l Online |c UC-FullText |u https://link.springer.com/10.1007/978-3-319-57520-9 |z Springer Nature |g ebooks |i 12546496 | ||